Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  European Archives of Psychiatry and Clinical Neuroscience

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 1504110
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: Interactions with Yohimbine

  2004cited by this paper
• Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

  2004cited by this paper
• Anxiogenic properties of yohimbine. II. Influence of experimental set and setting.

  1992cited by this paper
• Response to 35% CO2 as a marker of panic in severe anxiety.

  1990cited by this paper
• The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air.

  1989cited by this paper
• Electroencephalographic sleep in panic disorder. A focus on sleep-related panic attacks.

  1989cited by this paper
• A neuroanatomical hypothesis for panic disorder.

  1989cited by this paper
• Sleep panic attacks: new clinical findings and theoretical implications.

  1989cited by this paper
• Isoproterenol-induced panic attacks.

  1988cited by this paper
• Ventilatory physiology of patients with panic disorder.

  1988cited by this paper
• Measurement of lactate-induced panic and anxiety.

  1987cited by this paper
• Serotonin function in anxiety

  1987cited by this paper
• Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.

  1987cited by this paper
• Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment.

  1986cited by this paper
• Autonomic correlates of sensation seeking and monoamine oxidase activity: using confirmatory factor analysis on psychophysiological data.

  1986cited by this paper
• Sodium lactate infusions and panic attacks: a review and critique.

  1986cited by this paper
• Cognitive mediation in the affective component of spontaneous panic attacks.

  1986cited by this paper
• A cognitive approach to panic.

  1986cited by this paper
• Cognitive determinants of lactate-induced anxiety.

  1986cited by this paper
• Lactate provocation of panic attacks. II. Biochemical and physiological findings.

  1985cited by this paper
• Increased anxiogenic effects of caffeine in panic disorders.

  1985cited by this paper
• Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.

  1985cited by this paper
• Panic Symptoms after Inhalation of Carbondioxide

  1984cited by this paper
• Liquid chromatographic assay for CSF catecholamines using electrochemical detection.

  1984cited by this paper
• Caffeine: relationship to human anxiety, plasma MHPG and cortisol.

  1984cited by this paper
• Adrenergic function in patients with panic anxiety.

  1984cited by this paper
• Fear and anxiety: relationship to noradrenergic function.

  1984cited by this paper
• Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.

  1984cited by this paper
• Femtogram detection limits for biogenic amines using microbore HPLC with electrochemical detection.

  1984cited by this paper
• Psychophysiological factors in panic disorder.

  1984cited by this paper
• Response to hyperventilation in a group of patients with panic disorder.

  1984cited by this paper
• A comparison of lactate and isoproterenol anxiety states.

  1984cited by this paper
• Sodium lactate infusion, panic attacks, and ionized calcium.

  1984cited by this paper
• Panic anxiety: a new biological model.

  1984cited by this paper
• Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.

  1983cited by this paper
• Pharmacologic models of anxiety.

  1983cited by this paper
• Panic Disorders: Current Perspectives

  1982cited by this paper
• Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems.

  1979cited by this paper
• Somatic anxiety attacks and propranolol.

  1976cited by this paper
• A rating instrument for anxiety disorders.

  1971cited by this paper
• Direct measurement of skin conductance: a proposal for standardization.

  1971cited by this paper
• Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness.

  1969cited by this paper
• Yohimbine as an Autonomic Test Drug

  1962cited by this paper
• A continuous performance test of brain damage.

  1956cited by this paper

• Oxytocin Attenuates Yohimbine-Induced Responding for Oral Oxycodone under a Progressive Ratio Schedule in Male and Female Rats.

  2025cites this paper
• Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences.

  2020cites this paper
• Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework

  2018cites this paper
• Effects of Mental Stress Induction on Heart Rate Variability in Patients with Panic Disorder

  2017cites this paper
• An elevated plus-maze in mixed reality for studying human anxiety-related behavior

  2017cites this paper
• Can Interoception Improve the Pragmatic Search for Biomarkers in Psychiatry?

  2016cites this paper
• Anxiety-Inducing Dietary Supplements: A Review of Herbs and Other Supplements with Anxiogenic Properties

  2014cites this paper
• Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view

  2014cites this paper
• Modeling relapse in animals.

  2013cites this paper
• Avoidant coping in panic disorder: a yohimbine biological challenge study

  2012cites this paper
• Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals

  2012cites this paper
• Different measures of impulsivity in patients with anxiety disorders: a case control study.

  2012cites this paper
• Exploring exercise as an avenue for the treatment of anxiety disorders

  2012cites this paper
• Psychological and Neuroendocrine Responses to Social Stress and to the Administration of the alpha-2-Receptor Antagonist, Yohimbine, in Highly Trained Endurance Athletes in Comparison to Untrained Healthy Controls

  2011cites this paper
• FACTORES POTENCIALES DE RIESGO PARA SÍNDROME DE PÁNICO

  2010cites this paper
• Regional cerebral metabolic rate (positron emission tomography) during inhalation of nitrous oxide 50% in humans.

  2008cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL FACULDADE DE MEDICINA PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA: CIÊNCIAS MÉDICAS USO DE HIDRATO DE CLORAL PARA SEDAÇÃO EM UNIDADE DE TRATAMENTO INTENSIVO PEDIÁTRICA: INDICAÇÕES, EFEITOS ADVERSOS E FATORES DE RISCO ASSOCIADOS

  2008cites this paper
• Modelling anxiety in humans for drug development.

  2007cites this paper
• Use of nitrous oxide and oxygen for conscious sedation to manage pain and anxiety.

  2007cites this paper
• The myth of panic spontaneity: Consideration of behavioral and neurochemical sensitization.

  2007cites this paper
• A comparison of oral midazolam and nitrous oxide sedation for dental extractions in children

  2006cites this paper
• Modification of Behavior With 50% Nitrous Oxide/Oxygen Conscious Sedation Over Repeated Visits for Dental Treatment A 3-Year Prospective Study

  2006cites this paper
• Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers

  2005cites this paper
• Preemptive analgesia at the crossroad.

  2005cites this paper
• Anxiety disorders: noradrenergic neurotransmission.

  2005cites this paper
• Does the panic attack activate the hypothalamic-pituitary-adrenal axis?

  2005cites this paper
• Anxiogenic properties of yohimbine

  2005cites this paper
• Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal

  2005cites this paper
• The genetics of panic disorder: state of the art

  2004cites this paper
• Adrenergic transmission facilitates extinction of conditional fear in mice.

  2004cites this paper
• A partially blinded randomised controlled trial of patient‐maintained propofol sedation and operator controlled midazolam sedation in third molar extractions

  2004cites this paper
• Pharmacological Blockade of α2-Adrenoceptors Induces Reinstatement of Cocaine-Seeking Behavior in Squirrel Monkeys

  2004cites this paper
• Cardiovascular effects of xenon and nitrous oxide in patients during fentanyl‐midazolam anaesthesia *

  2004cites this paper
• Neuroanatomical circuits modulating fear and anxiety behaviors

  2003cites this paper
• Randomized, controlled, cross-over clinical trial comparing intravenous midazolam sedation with nitrous oxide sedation in children undergoing dental extractions.

  2003cites this paper
• Nitrous Oxide Attenuates Pressor but Augments Norepinephrine Response to Laryngoscopy and Endotracheal Intubation

  2003cites this paper
• 63 NEUROBIOLOGICAL BASIS OF ANXIETY DISORDERS

  2002cites this paper
• A randomised, controlled, crossover trial of oral midazolam and nitrous oxide for paediatric dental sedation

  2002cites this paper
• Biological basis of anxiety and strategies for pharmacological innovation

  2002cites this paper
• Antidepressants in social anxiety disorder.

  2001cites this paper
• Patient-administered nitrous oxide/oxygen inhalation provides safe and effective analgesia for percutaneous liver biopsy: a randomized placebo-controlled trial.

  2001cites this paper
• Autonomic dysregulation in panic disorder and in post-traumatic stress disorder: application of power spectrum analysis of heart rate variability at rest and in response to recollection of trauma or panic attacks.

  2000cites this paper
• Polymorphism in the promoter region of the alpha(2A)-adrenergic receptor gene and panic disorders.

  2000cites this paper
• Antinociceptive Action of Nitrous Oxide Is Mediated by Stimulation of Noradrenergic Neurons in the Brainstem and Activation of α2B Adrenoceptors

  2000cites this paper
• Differential association of traits of fear and anxiety with norepinephrine- and dark-induced pupil reactivity.

  1999cites this paper
• Prevention by 5-HT1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat.

  1999cites this paper
• Adrenergic receptor function in panic disorder II. Neutrophil β2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome

  1999cites this paper
• CCK4-induced panic in healthy subjects II: neurochemical correlates.

  1999cites this paper
• Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome.

  1999cites this paper
• Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome.

  1999cites this paper
• Analysis of heart rate variability in posttraumatic stress disorder patients in response to a trauma-related reminder.

  1998cites this paper
• Neurobiology of panic disorder.

  1998cites this paper
• Psychoneuroendocrinology of anxiety disorders.

  1998cites this paper
• a 2-Adrenergic modulation of colonic tone during hyperventilation

  1997cites this paper
• Modulation of central noradrenaline efflux by pharmacological and novel environmental stimuli : a microdialysis study.

  1997cites this paper
• α2-Adrenergic modulation of colonic tone during hyperventilation.

  1997cites this paper
• Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls.

  1997cites this paper
• Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model.

  1996cites this paper
• Stress‐ and Yohimbine‐Induced Release of Cholecystokinin in the Frontal Cortex of the Freely Moving Rat: Prevention by Diazepam but Not Ondansetron

  1996cites this paper
• Neurochemical mediators of anxiety have inconsistent effects on hypothalamic self-stimulation in rats.

  1996cites this paper
• Autonomic activity in relation to cerebrospinal fluid neurochemistry in obsessive and disruptive children and adolescents.

  1996cites this paper
• Cholecystokinin in anxiety.

  1996cites this paper
• Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against α2-adrenoceptor mediation

  1995cites this paper
• The association of urinary 5-hydroxyindoleacetic acid and vanillylmandelic acid in patients with generalized anxiety.

  1995cites this paper
• Behavioral, neurochemical, anatomical and electrophysiological correlates of panic disorder: multiple transmitter interaction and neuropeptide colocalization.

  1995cites this paper
• Anxiety and growth disturbance: is there a connection? A review of biological studies in social phobia.

  1994cites this paper
• Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine.

  1993cites this paper
• The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5‐HT release in the frontal cortex of freely‐moving rats

  1993cites this paper
• Anxiogenic properties of yohimbine. II. Influence of experimental set and setting.

  1992cites this paper